Date post: | 23-Dec-2015 |
Category: |
Documents |
Upload: | prosper-reed |
View: | 218 times |
Download: | 0 times |
MODULE 5
1/46
Case 2: Troy
MODULE 5Case 2: Troy
2/46
Patient History
Troy is a 59 year old retired school teacher who comes to you for his annual physical
He is overweight and during routine questioning, you ask Troy if he has any urinary problems
Troy says his body is not what it used to be and now that you mention it, he has been meaning to ask about the frequency of his urination, which seems a bit abnormal, but maybe its just part of getting old!
MODULE 5Case 2: Troy
3/46
What Questions Do You Have About Troy’s History?
MODULE 5Case 2: Troy
4/46
1. What is the frequency of your urination per day?
2. How many times are you up to void at night?
3. Have you experienced any recent weight gain?
4. Do you have a family history of diabetes?
5. Is your stream strong and forceful?
6. Is there is any blood in your urine?
7. Do you have any problems with your erections, interest in sex, ejaculation?
8. Do you have the urgent need to void? Are you able to empty your bladder well?
9. Ask questions pertaining to signs of infection i.e. Burning sensation when voiding
Possible Questions
MODULE 5Case 2: Troy
5/46
Troy’s Response
Troy reports he has to void 2 to 4 times per night, as well as sporadic lower back pain, especially when driving
He thinks the problem is aggravated by red meat consumption and caffeine intake (he still is in the habit of drinking 2 to 3 cups of coffee a day)
He thinks the problem started a while ago, but he has really noticed it over the past 6 months
MODULE 5Case 2: Troy
6/46
Obstructive Symptoms of LUTS
Further questioning of Troy reveals obstructive symptoms of LUTS, including a weak stream and a sensation of incomplete voiding
In addition, Troy has some urinary frequency and urgency
When asked about physical activity, Troy says he doesn’t do much and even though he feels he needs to go on a diet, he hasn’t had much luck losing weight since he quit smoking 15 years ago
LUTS = Lower Urinary Tract Symptoms
MODULE 5Case 2: Troy
7/46
How Would You Assess the Impact of Troy’s Urinary Problems on his Quality of Life?
MODULE 5Case 2: Troy
8/46
Use of Questionnaires:
1. IPSS (or AUA symptom score)2. Quality of life question
IPSS = International Prostate Symptom ScoreAUA = American Urological Association
MODULE 5Case 2: Troy
9/46
Discussion The IPSS and Quality of Life due to Urinary Symptoms
Questionnaires are requested of Troy
You ask him to complete the forms before proceeding
Here are Troy’s scores:
International Prostate Symptom Score (IPSS)
Patient name: Troy
DOB: 05/05/46
ID: 0019-0022
Date of assessment: 29/06/05
Initial assessment (X)
Monitor: during __X__ therapy after _____therapy/surgery
MODULE 5Case 2: Troy
10/46
International Prostate Symptom Score
Not at all
Less than 1 timein 5
Less than half the time
About half the
time
More than half the time
Almost always
Troy’s Results
1. Over the past month, how often have you had a sensation of not emptying your bladder completely after you finished urinating?
0 1 2 3 4 5 3
2. Over the past month, how often have you had to urinate again less than two hours after you finished urinating?
0 1 2 3 4 5 4
3. Over the past month, how often have you found you stopped and started again several times when you urinated?
0 1 2 3 4 5 1
4. Over the past month, how often have you found it difficult to postpone urinating?
0 1 2 3 4 5 4
MODULE 5Case 2: Troy
11/46
Not at all
Less than 1 timein 5
Less than half the time
About half the
time
More than half the time
Almost always
Troy’s Results
5. Over the past month, how often have you had a weak urinary stream?
0 1 2 3 4 5 2
6. Over the past month, how often have you had to push or strain to begin urinating?
0 1 2 3 4 5 1
None 1 time 2 times 3 times 4 times5 or
more times
Troy’s Results
7. Over the past month, how many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning?
0 1 2 3 4 5 2
Total IPSS Score = 17
MODULE 5Case 2: Troy
12/46
Troy’s QoL Score = 4 (Mostly Dissatisfied)
Quality of Life Due to Urinary Symptoms
Delighted PleasedMostly
Satisfied
Mixed about equally
satisfied and dissatisfied
Mostly dissatis-
fiedUnhappy Terrible
1. If you were to spend the rest of your life with your urinary condition just the way it is now, how would you feel about that?
0 1 2 3 4 5 6
MODULE 5Case 2: Troy
13/46
How Do You Interpret the Severity and Bother Associated with Troy’s Symptoms?
MODULE 5Case 2: Troy
14/46
Interpreting the IPSS and Bother Score
IPSS Values Indicate Symptom Severity:
Mild score: ≤ 7Moderate score: 8-19Severe score: ≥ 20
• Troy’s IPSS = 17 (moderate symptoms)
• Troy’s Bother Score = 4 (mostly dissatisfied)
IPSS = International Prostate Symptom Score
MODULE 5Case 2: Troy
15/46
Discussion
The IPSS revealed a score of 17
This is a score of moderate severity and perhaps explains why Troy has been somewhat reluctant to seek treatment
He scores a 4 on the quality of life question, being mostly dissatisfied with his condition
IPSS = International Prostate Symptom Score
MODULE 5Case 2: Troy
16/46
What Physical Examinations Would You Undertake on Troy?
MODULE 5Case 2: Troy
17/46
Recommended
Examinations:
1. Abdominal exam
2. Genital exam
3. DRE
DRE = Digital Rectal Examination
MODULE 5Case 2: Troy
18/46
Physical Examination Results
Height 5 ft 6"
Weight 100 kg (220 lb)
Blood Pressure 122/80 mmHg
Abdominal Exam Normal
Genital Exam Normal
DRE:- Anus & Rectal Ampulla- Prostate
- Normal
- Moderately enlarged, firm and smooth but has no nodules
DRE = Digital Rectal Examination
MODULE 5Case 2: Troy
19/46
What Are the Possible Diagnoses You Are Considering for Troy?
MODULE 5Case 2: Troy
20/46
Possible Diagnoses
1. BPH
2. Prostate cancer
3. Prostatitis
4. Diabetes
5. Neurogenic bladder
6. Bladder outlet obstruction
7. Urethral stricture
8. Urinary tract infection
9. Bladder cancer
10. Bladder stone
BPH = Benign Prostatic Hyperplasia
MODULE 5Case 2: Troy
21/46
What Investigations Might You Consider for Troy at this Stage?
MODULE 5Case 2: Troy
22/46
Lab tests: Urinalysis: no abnormal findings
Serum creatinine: 72 μmol/L
PSA: 1.8 ng/mL
Blood/Glucose: normal
Midstream urine for C & S (culture and sensitivity): normal
Lab Results
PSA = Prostate-Specific Antigen
MODULE 5Case 2: Troy
23/46
Discussion of Lab Results
Troy appears to have moderate symptoms of BPH
Urinalysis shows no evidence of pyuria or bacteria, ruling out infectious syndromes
The serum creatinine is also normal
Troy’s PSA level is normal
BPH = Benign Prostatic HyperplasiaPSA = Prostate-Specific Antigen
MODULE 5Case 2: Troy
24/46
What is the Most Likely Diagnosis for Troy?
MODULE 5Case 2: Troy
25/46
Diagnosis
On the basis of the normal lab results, his symptoms, and the smooth, firm enlargement of his prostate, Troy is diagnosed with BPH
Before any treatment strategies are initiated Troy is counseled about this diagnosis
He is reassured that it is a benign disease but that it may progress, or symptoms may stay the same or improve
Surgery is not recommended to Troy
Diagnosis: BPH
BPH = Benign Prostatic Hyperplasia
MODULE 5Case 2: Troy
26/46
What Would be Your Management Strategy for Troy?
MODULE 5Case 2: Troy
27/46
Management Strategy Troy is offered the options of either watchful waiting or pharmacological
treatment
Troy elects pharmacologic treatment:
Troy is prescribed combination therapy with a 5α–reductase inhibitor and an α1-blocker
This combination should relieve the obstructive symptoms, as well as shrink his prostate
A moderate exercise regime is recommended for Troy, as well as cutting back on his red meat and caffeine intake
Troy says he is relieved to know that his problem is not likely to be related to cancer because he has a friend who recently died from that disease
MODULE 5Case 2: Troy
28/46
Note:
Combination therapy results in more symptom amelioration than either medication alone
In addition it has the best possibility of preventing BPH progression (prevents future deterioration of symptoms, acute urinary retention and eventual surgery)
Troy’s Treatment Rationale
Combination Therapy:
1. 5α – reductase inhibitor
AND
2. α1- blocker
Shrink the gland
AND
Relieve theobstructive symptoms
Treatment Strategy
BPH = Benign Prostatic Hyperplasia
MODULE 5Case 2: Troy
29/46
Discussion
α1-blockers work quickly to reduce symptoms while 5α-reductase inhibitors slowly reduce the size of the prostate and eventually reduce symptoms
It is the reduction in size of the prostate and prevention of growth that results in prevention of BPH progression
BPH = Benign Prostatic Hyperplasia
MODULE 5Case 2: Troy
30/46
When Would You Expect Troy’s Treatment Options to Show Some Effect?
MODULE 5Case 2: Troy
31/46
Time to Effect
Time to take effect: α1-blocker: a few days – 1 week
5α-reductase inhibitor : up to six months
MODULE 5Case 2: Troy
32/46
Troy Asks About Phytotherapy for BPH. What Do You Tell Him?
BPH = Benign Prostatic Hyperplasia
MODULE 5Case 2: Troy
33/46
Would You Do Anything Different if Troy had High Blood Pressure and was Taking
Antihypertensive Medication?
MODULE 5Case 2: Troy
34/46
Discussion Regarding Thiazide Diuretics
If Troy was taking a thiazide diuretic:
Non-selective α1- blockers, such as terazosin and doxazosin, may cause postural hypotension in patients already receiving antihypertensives
Non selective α1- blockers are no longer indicated as first line agents for the treatment of hypertension because of adverse outcomes (see Canadian Hypertension Guidelines - http://www.hypertension.ca)
Non-selective α1- blockers by themselves are not a good choice for monotherapy to treat BPH and hypertension
The selective α1- blockers, tamsulosin and alfuzosin do not tend to cause clinically significant hypotension and can be used in conjunction with thiazide diuretics
BPH = Benign Prostatic Hyperplasia
MODULE 5Case 2: Troy
35/46
What Would Be Your Follow-up Strategy For Troy?
MODULE 5Case 2: Troy
36/46
Follow-up Strategy
Following your instructions, Troy will make sure he requests an IPSS and QoL questionnaire from the receptionist each time he arrives for his follow up appointments
He will come about 10 minutes early for his appointment so he can fill it out in the waiting room before he sees you
IPSS = International Prostate Symptom ScoreQoL = Quality of Life
MODULE 5Case 2: Troy
37/46
Follow-up Appointments for Troy
What Would your Likely Course of Action be at Each Visit?
MODULE 5Case 2: Troy
38/46
Follow-up Appointments for Troy
2 weeks If a non-selective agent has been chosen the dose must be titrated upward balancing effectiveness against hypotension
Selective α1-blockers do not need titration and we might expect some improvement of symptoms at this stage
Maintain the 5α-reductase inhibitor
4-6 weeks Troy reports mild relief of his urinary symptoms The dose of selective α1-blocker is maintained The dose of the non-selective α1-blocker may need to be titrated
depending on his extent of symptom relief Maintain the 5α-reductase inhibitor
3 months Moderate symptom relief is reported The dose of non-selective or selective α1-blockers is maintained Maintain the 5α-reductase inhibitor
MODULE 5Case 2: Troy
39/46
6 months He reports moderate relief of irritative and obstructive symptoms His score on the IPSS has dropped from 17 to 12 He answers 3 to the quality of life question (less bother) The dose of α1-blocker is maintained Maintain the 5α-reductase inhibitor
9 months If Troy’s 6 month visit is promising, this visit can be skipped Monitor Troy’s urinary symptoms The dose of α1-blocker is maintained Maintain the 5α-reductase inhibitor
IPSS = International Prostate Symptom Score
MODULE 5Case 2: Troy
40/46
Discussion
What do you expect Troy’s PSA value to be at 12 months?
How frequently would you perform the DRE?
What examinations and tests would you perform at 1 year?
When, if ever, would you consider changing his therapy?
PSA = Prostate-Specific AntigenDRE = Digital Rectal Examination
MODULE 5Case 2: Troy
41/46
12 months Troy’s IPSS is now 10 and he has greatly improved His quality of life has improved (no bother) Perform a physical exam including DRE, urinalysis, and PSA, and
serum creatinine is optional The dose of α1-blocker is maintained Maintain the 5α-reductase inhibitor His PSA is 0.8ng/ml DRE: Normal
1 - 2 years An option is to remove Troy from the α1-blocker and see if he still requires it for symptom relief
Maintain the 5α-reductase inhibitor
Yearly follow-ups
Unless Troy experiences increased severity of symptoms, a yearly DRE and PSA is recommended as well as IPSS and QoL
Note: Troy’s DRE is normal and his PSA levels have reduced and there is no need to refer him to a urologist
IPSS = International Prostate Symptom ScorePSA = Prostate-Specific AntigenDRE = Digital Rectal ExaminationQoL = Quality of Life
MODULE 5Case 2: Troy
42/46
Long Term Management
How would you manage Troy after 2 or 3 years if he no longer has any bothersome symptoms based on his IPSS and QoL?
IPSS = International Prostate Symptom ScoreQoL = Quality of Life
MODULE 5Case 2: Troy
43/46
Long Term Management
Consider stopping the α1-blocker and see if he still needs it.
Continue to monitor DRE and PSA as usual routine.
DRE = Digital Rectal ExaminationPSA = Prostate-Specific Antigen
MODULE 5Case 2: Troy
44/46
Long Term Management
What kind of lifestyle options would you counsel Troy on, to help with his symptoms?
MODULE 5Case 2: Troy
45/46
Long Term Management
If he wants to take multivitamins, consider vitamin E and selenium and perhaps lycopenes since they may be shown in future studies to be important for prevention of prostate cancer.
He no longer has any bothersome symptoms so no direct advice other than:
Good diet
Exercise
Avoidance of anything that causes recurrence of his symptoms
MODULE 5Case 2: Troy
46/46
End of Case 2